PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

Clinical trial NCT00238329 · COMPLETED

Trial details

NCT number: NCT00238329
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intraocular Melanoma Melanoma (Skin)

Start date: 2001-01-01
Primary completion: 2005-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.